Skip to search formSkip to main contentSkip to account menu

BG 9928

Known as: BG-9928, BG9928 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Cisplatin (CIS),is nephrotoxic due to renal vasoconstriction and decreased GFR, effects believed to involve of adenosine mediated… 
2008
2008
Gateways to Clinical Trials are a guide to the most recent clinical trials in current literature and congresses. The data in the… 
2006
2006
Novel tricyclic imidazoline antagonists of the adenosine A1 receptor are described. For key compounds, the selectivity level over… 
2005
2005
Biogen Idec, under license from CV Therapeutics, is developing BG-9928, a selective oral adenosine A, receptor antagonist, for… 
Review
2004
Review
2004
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the… 
2003
2003
Stimulation of A1adenosine receptors in the kidney reduces glomerular filtration rate (GFR) via tubuloglomerular feedback and…